High proportion of fluoroquinolone mono-resistant mycobacterium tuberculosis (MTB) strains in Pakistan (2010-2012)

K. Jabeen, F. Malik, R. Hasan (Karachi, Pakistan)

Source: Annual Congress 2013 –Drug-resistant tuberculosis
Session: Drug-resistant tuberculosis
Session type: Thematic Poster Session
Number: 2824
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Jabeen, F. Malik, R. Hasan (Karachi, Pakistan). High proportion of fluoroquinolone mono-resistant mycobacterium tuberculosis (MTB) strains in Pakistan (2010-2012). Eur Respir J 2013; 42: Suppl. 57, 2824

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Multidrug–resistant tuberculosis in Czech Republic during the period of recent 5 years (2007-2012)
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013


Influence of mycobacterium tuberculosis strains on recurrence of tuberculosis in Hanoi, Vietnam
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015

Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015

Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus – 2009-2010
Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Year: 2013


Features of different M.tuberculosis strains that were isolated from MDR-TB patients in Kharkiv, Ukraine
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016


Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


Universal genotyping of Mycobacterium tuberculosis (MTb) in Singapore, 2011-2017
Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity
Year: 2018



The top of the iceberg - Extensively drug resistant tuberculosis (XDR-TB) in 2010
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


Transmission of MDR-TB by a Haarlem genotype mycobacterium tuberculosis strain among native Greeks
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013

Genotypes of mycobacterium tuberculosis with pre-extended drug resistance in Belarus
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016

Predisposing factors of multi drug resistant tuberculosis (MDR-TB) in Sardjito Hospital, Yogyakarta, Indonesia in 2009-2012
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014

Indicators of rifampicin-resistant TB response in Belarus, 2009-2014
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Transmission of mycobacterium tuberculosis Ural 163-15 lineage causing multidrug-resistant tuberculosis among hospitalized patients
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Genetic diversity of multidrug resistant mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran, using MIRU-VNTR technique
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016

Management of MDR and rifampicin-resistant TB cases in Italy, 1995-1999
Source: Eur Respir J 2001; 18: Suppl. 33, 513s
Year: 2001

Characterization of mycobacterium abscessus subtypes in Shanghai: The drug sensitivity, bacterial epidemicity and clinical manifestations
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016


Comparision of line probe assay and conventional methos for detection of mycobacteria other than tuberculosis (MOTT) strains from patients suferring from pulmonary tuberculosis
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Fifteen years period (2000-2014) of resistant TB forms in Vojvodina (Serbia)
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Genotypes of mycobacterium tuberculosis isolates from autopsy material of HIV-positive tuberculosis patients in Russia
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015


Trend and risk factors of drug resistance tuberculosis between 2005-2012 in Istanbul, Turkey
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015